Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

How Will the Pneumococcal Vaccine Market Grow from 2024 to 2033?

The market size of the pneumococcal vaccine has seen significant growth in the past several years. It is projected to expand from $8.47 billion in 2023 to $9.04 billion in 2024, marking a compound annual growth rate (CAGR) of 6.7%. The upward trend during the historic period is a result of the identification of streptococcus pneumoniae, issues of public health, initiatives for early vaccination, progress in healthcare, and alterations in vaccine policies.

In the coming years, robust growth is anticipated in the pneumococcal vaccine market. The market is set to expand to $11.36 billion by 2028, growing at a compound annual growth rate (CAGR) of 5.9%. The predicted growth during the forecast period can be credited to the evolution of pneumococcal strains, ongoing research and development activities, prioritizing immunization, increased access to vaccines, and aging population. The forecast period is also likely to see key trends such as the development of multivalent vaccines, targeted vaccination for high-risk groups, efforts to improve vaccine effectiveness, and campaigns to raise awareness and education, with a focus on immunization of infants.

Claim Your Free Sample of the Global Pneumococcal Vaccine Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=11950&type=smp

What Aspects Are Influencing the Growth Rate of the pneumococcal vaccine Market?

The continued rise in the occurrence of pneumococcal infections is set to boost the pneumococcal vaccine market’s expansion. Pneumococcal infections are caused by a bacterium known as Streptococcus pneumoniae or pneumococcus, leading to pneumonia, bloodstream infections, ear, and sinus infections. The pneumococcal vaccine prompts the body to make antibodies against pneumococcal bacteria, reducing or eliminating bacteria and toxins that cause diseases, thus safeguarding children, the elderly, and individuals with compromised immune systems from various pneumococcal infections. For example, as of January 2022, Pneumococcal pneumonia, per the U.S. public health agency, the Center for Disease Control and Prevention, is responsible for approximately 150,000 hospitalizations annually in the U.S., contributing to almost 30% of adult community-acquired pneumonia. Consequently, the escalating incidence of pneumococcal complications stimulates the pneumococcal vaccine market’s progress.

What Are the Critical Segments of the Pneumococcal Vaccine Market?

1) By Product Type: Prevnar 13, Synflorix, Pneumovax23, Other Products

2) By Route of Administration: Intravenous, Intramuscular, Subcutaneous

3) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels

4) By End User: Pediatrics, Adults

What Trends Are Redefining Consumer Expectations in the Pneumococcal Vaccine Market?

Reputed companies in the pneumococcal vaccine market are introducing new products to enhance their market profitability. An exemplary instance is that of Merck & Co Inc., an American pharmaceutical firm, which launched the V116 vaccine in July 2023. Intended to counter the eight unique serotypes of Streptococcus pneumoniae, the primary cause for adult pneumococcal disease, V116 outperforms other vaccines in terms of immunogenicity for various serotypes in adult demographics. It has also elicited strong immune responses in both individuals not previously vaccinated and those who have been. The notable V116 has received breakthrough therapy designation by the U.S. Food and Drug Administration (FDA), currently progressing into its Phase 3 development.

Order Now for Fast Delivery of Your Pneumococcal Vaccine Market Report!

https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report

What Are the Leading Regions in the Pneumococcal Vaccine Market Expansion?

North America was the largest region in the pneumococcal vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumococcal vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Pneumococcal Vaccine Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the pneumococcal vaccine market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Pneumococcal Vaccine Market Include

1. Pneumococcal Vaccine Market Executive Summary

2. Pneumococcal Vaccine Market Segments

3. Pneumococcal Vaccine Market Size And Template Market Growth Rate

4. Key Pneumococcal Vaccine Market Trends

5. Major Pneumococcal Vaccine Market Drivers

……

25. Key Mergers And Acquisitions In The Pneumococcal Vaccine Market

26. Top Pneumococcal Vaccine Companies

27. Pneumococcal Vaccine Market Opportunities And Strategies

28. Pneumococcal Vaccine Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Pediatric Vaccine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Adult Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

DTP Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: